Cryomass Technologies Valuation
| CRYM Stock | USD 0.02 0.0001 0.50% |
Cryomass Technologies seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cryomass Technologies from analyzing the firm fundamentals such as Current Valuation of 42.41 M, return on equity of -1.16, and Shares Owned By Insiders of 25.92 % as well as examining its technical indicators and probability of bankruptcy. . In general, most investors favor obtaining undervalued instruments and abandoning overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Cryomass Technologies' price fluctuation is out of control at this time. Calculation of the real value of Cryomass Technologies is based on 3 months time horizon. Increasing Cryomass Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Cryomass otc stock is determined by what a typical buyer is willing to pay for full or partial control of Cryomass Technologies. Since Cryomass Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cryomass OTC Stock. However, Cryomass Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.02 | Real 0.0182 | Hype 0.02 | Naive 0.0216 |
The intrinsic value of Cryomass Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cryomass Technologies' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cryomass Technologies helps investors to forecast how Cryomass otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cryomass Technologies more accurately as focusing exclusively on Cryomass Technologies' fundamentals will not take into account other important factors: Cryomass Technologies Total Value Analysis
Cryomass Technologies is currently anticipated to have valuation of 42.41 M with market capitalization of 35.44 M, debt of 177.08 K, and cash on hands of 2.19 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cryomass Technologies fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.41 M | 35.44 M | 177.08 K | 2.19 M |
Cryomass Technologies Asset Utilization
One of the ways to look at asset utilization of Cryomass is to check how much profit was generated for every dollar of assets it reports. Cryomass Technologies shows a negative utilization of assets of -0.33 percent, losing $0.003296 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cryomass Technologies shows how discouraging it operates for each dollar spent on its assets.Cryomass Technologies Ownership Allocation
Cryomass Technologies holds a total of 202.53 Million outstanding shares. Cryomass Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cryomass Technologies Profitability Analysis
Net Loss for the year was (12.86 M) with profit before overhead, payroll, taxes, and interest of 37.18 K.About Cryomass Technologies Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Cryomass Technologies. In general, an absolute valuation paradigm, as applied to this otc stock, attempts to find the value of Cryomass Technologies based exclusively on its fundamental and basic technical indicators. By analyzing Cryomass Technologies's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Cryomass Technologies's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cryomass Technologies. We calculate exposure to Cryomass Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cryomass Technologies's related companies.Cryomass Technologies Inc. designs, sells, and commercializes cryo-mechanical system for the handling of harvested hemp, cannabis, and other high-value plants. Cryomass Technologies Inc. was incorporated in 2011 and is headquartered in Denver, Colorado. Cryomass Technologies operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Cryomass Technologies' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Cryomass Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cryomass Technologies' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cryomass Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cryomass Technologies' revenue streams: Identify Cryomass Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cryomass Technologies' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cryomass Technologies' growth potential: Evaluate Cryomass Technologies' management, business model, and growth potential.
- Determine Cryomass Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cryomass Technologies' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cryomass Technologies Growth Indicators
Investing in growth stocks can be very risky. If the company such as Cryomass Technologies does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 196.9 M | |
| Retained Earnings | -28.6 M | |
| Shares Float | 147.1 M |
Other Information on Investing in Cryomass OTC Stock
Cryomass Technologies financial ratios help investors to determine whether Cryomass OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cryomass with respect to the benefits of owning Cryomass Technologies security.